Physician profile
David Roger Abrahams
NPI 1083610786
$446.58
in general payments reported to CMS, 2019-2025
14 companies · $190 in 2025
The $190 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.19 · 2021: $36.56 · 2022: $69.06 · 2023: $32.73 · 2024: $62.13 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $74.03 | 2023-2025 | Entyvio |
| Nevro Corp. | $56.19 | 2019 | |
| Merck Sharp & Dohme LLC | $36.56 | 2021 | |
| Madrigal Pharmaceuticals | $35.16 | 2025 | Rezdiffra |
| Phathom Pharmaceuticals, INC. | $31.87 | 2024 | Voquezna |
| Celltrion USA INC. | $28.64 | 2025 | Vegzelma |
| Qol Medical, LLC | $27.83 | 2025 | Sucraid |
| Redhill Biopharma INC. | $26.41 | 2022 | |
| Abbvie INC. | $24.72 | 2025 | |
| Braintree Laboratories, INC. | $23.69 | 2025 | Suflave, Sutab |
| Exact Sciences Corporation | $23.25 | 2025 | The Cologuard Plus Collection Kit |
| Ironwood Pharmaceuticals, INC | $21.71 | 2022 | |
| Ardelyx, INC. | $20.94 | 2022 | |
| Mauna Kea Technologies, INC. | $15.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Abrahams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.